Zum Inhalt springen

Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer 

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, today announced that it has appointed Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer effective June 3, 2024. Dr. Knobelman will oversee the finance, accounting, business development, investor relations and corporate strategy functions. Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer 

Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway

Warsaw, 21st May 2024 – Molecure S.A. (‘Molecure’, WSE ticker: MOC), a biotechnology company that discovers and develops drugs to the clinical stage, leveraging its globally unique expertise in medicinal chemistry and biology to explore and develop first-in-class small molecule drugs that directly modulate protein activity and mRNA function for the treatment of multiple incurable diseases, announces today that it has received national regulatory approvals from Denmark, France, Greece, Germany and Norway to conduct a Phase II clinical trial for OATD-01, a first-in-class chitotriosidase 1 (CHIT1) inhibitor with disease-modifying potential in pulmonary sarcoidosis. Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway

Vogelgrippe tötet Hälfte der Infizierten

Nach Angaben der Weltgesundheitsorganisation (WHO) wurden seit 2003 aus 23 Ländern 888 Fälle menschlicher Infektionen mit dem Vogelgrippevirus, auch bekannt als H5N1, gemeldet, von denen 463 tödlich verliefen. Vietnam, Kambodscha und Indonesien gehören zu den am schlimmsten betroffenen Ländern. „Obwohl die Zahl möglicherweise nicht so hoch erscheint wie bei vielen anderen Ausbrüchen, müssen wir bedenken, dass jede Infektion beim Menschen ein Versuch des Virus ist, sich in der menschlichen Bevölkerung festzusetzen“, sagt Wenqing Zhang , Leiter des globalen Grippeprogramms der WHO, in einem Video, das diese Woche (Montag) veröffentlicht wurde. „Obwohl die Chancen bisher gering sind, ist es der Beginn einer Grippepandemie, solange es nur einmal gelingt …“ Die Symptome beim Menschen reichen von leichten Problemen der oberen Atemwege bis hin zu schweren Erkrankungen wie Lungenentzündung und Multiorganversagen. Der jüngste Ausbruch bei Milchkühen in den USA deutet darauf hin, dass… 

PFAS schädigen Spermien und Nachwuchs

Die Ergebnisse eines Forscherteams zeigen, dass die Exposition gegenüber einer Mischung aus alten und neu auftretenden PFAS-Chemikalien bei erwachsenen männlichen Mäusen zu einer abweichenden Spermienmethylierung und einer veränderten Genexpression von Leber und Fett der Nachkommen auf geschlechtsspezifische Weise führt. Diese Daten deuten darauf hin, dass eine vorgefasste PFAS-Exposition bei Männern übertragen werden kann, um den Phänotyp in der nächsten Generation zu beeinflussen. Forscher der Wayne State University berichten über neue Erkenntnisse, die einen Zusammenhang zwischen der Exposition gegenüber per- und polyfluorierten Alkylsubstanzen (PFAS) bei Männern und Gesundheitsproblemen bei ihren Nachkommen belegen. Die kürzlich in Environment International veröffentlichte Studie „Mischungen aus Per- und Polyfluoralkylsubstanzen (PFAS) verändern die Spermienmethylierung und die langfristige Neuprogrammierung des Leber- und Fetttranskriptoms der Nachkommen“, untersuchte die Wirkung von PFAS-Mischungen auf das Spermienmethylom und Transkriptionsänderungen Stoffwechselgewebe der Nachkommen wie Leber und Fett. „PFAS-Forschung ist wichtig, insbesondere in Michigan“,… 

Understanding Laboratory Values in Cats

When it comes to the health of our feline friends, laboratory tests play a crucial role in diagnosing and monitoring various conditions. As a cat owner, understanding these lab values can help you better comprehend your cat’s health status and the care they may need. Common Laboratory Tests for Cats Complete Blood Count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in your cat’s blood. It can indicate conditions like anemia, infection, or inflammation. Blood Chemistry Panel: This panel includes tests for enzymes and other substances that can give insights into the health of your cat’s organs, such as the liver and kidneys. For example, elevated liver enzymes might suggest liver disease. Urinalysis: Examining your cat’s urine can help detect urinary tract infections, diabetes, and kidney problems. It assesses aspects like pH, concentration,… 

AI jobs climb and see up to 25% wage premium

Sectors more exposed to AI are experiencing almost five times (4.8x) higher growth in labour productivity, according to PwC’s inaugural 2024 Global AI Jobs Barometer, published today. The report, which analysed over half a billion job ads from 15 countries, suggests that AI could allow many nations to break out of persistent low productivity growth, generating economic development, higher wages, and enhanced living standards. The report finds that for every job posting requiring AI specialist skills (i.e., machine learning) in 2012, there are now seven job postings.[1] PwC research also finds that growth in jobs demanding AI skills has outpaced all jobs since 2016, with postings for jobs requiring AI skills growing 3.5x faster than for all jobs. The findings also highlight economic opportunity for labour forces: jobs that require AI skills carry up to a 25% average wage premium… 


Abu Dhabi Partners with Roche Pharmaceuticals

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Roche Pharmaceuticals Middle East during Abu Dhabi Global Healthcare Week (ADGHW). Under the MoU, the two entities will advance critical research using real-world data to study and assess the spinal muscular atrophy burden in Abu Dhabi, as well as assessing potential conduction of research and the facilitation of real-world data collection to monitor Duchenne Muscular Dystrophy (DMD) disease. In the presence of Dr. Rashed Alsuwaidi, the Executive Director of the Healthcare Workforce Planning Sector at DoH and Michael Oberreiter, Head of Global Access at Roche Pharmaceuticals, the MoU was signed by Dr. Asma Al Mannaei, the Executive Director of the Research and Innovation Centre at DoH and Mohamed Elshaarawy, General Manager Roche Pharmaceuticals, UAE

Abu Dhabi Partners with Roche Pharmaceuticals

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Roche Pharmaceuticals Middle East during Abu Dhabi Global Healthcare Week (ADGHW). Under the MoU, the two entities will advance critical research using real-world data to study and assess the spinal muscular atrophy burden in Abu Dhabi, as well as assessing potential conduction of research and the facilitation of real-world data collection to monitor Duchenne Muscular Dystrophy (DMD) disease. In the presence of Dr. Rashed Alsuwaidi, the Executive Director of the Healthcare Workforce Planning Sector at DoH and Michael Oberreiter, Head of Global Access at Roche Pharmaceuticals, the MoU was signed by Dr. Asma Al Mannaei, the Executive Director of the Research and Innovation Centre at DoH and Mohamed Elshaarawy, General Manager Roche Pharmaceuticals, UAE

AOK-Studie: Pflegende Angehörige müssen immer mehr leisten

Menschen, die zu Hause ihre Angehörigen pflegen, müssen dafür immer mehr Zeit und eigenes Geld aufwenden. Das ergibt sich aus einer Forsa-Umfrage im Auftrag des Wissenschaftlichen Instituts der AOK (Wido), über die die Zeitungen des „Redaktionsnetzwerks Deutschland“ berichten. Gaben die Befragten 2019 noch an, 43 Wochenstunden für pflegende Tätigkeiten wie Ernährung, Körperpflege und Medikamentengabe zu […] AOK-Studie: Pflegende Angehörige müssen immer mehr leisten

U.S. Patent and Trademark Office Grants US Patent # 11,975,112 for “Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine”

PARAMUS, N.J., May 20, 2024 (GLOBE NEWSWIRE) — Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the U.S. Patent and Trademark Office (USPTO) granted US Patent # 11,975,112 for “Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine”. U.S. Patent and Trademark Office Grants US Patent # 11,975,112 for “Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine”